Avoid. RDNT scores poorly across growth (18.2) and value (12) metrics, with a 83.8× forward P/E that offers no margin of safety. The structural vulnerability is acute: contracted radiology groups operate all medical services, and termination risk—coupled with tight labor markets for qualified radiologists—creates dependency on partners RDNT cannot directly control, threatening referral relationships and revenue stability.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for RDNT:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 17/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates RDNT (RDNT) at 17/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Avoid. RDNT scores poorly across growth (18.2) and value (12) metrics, with a 83.8× forward P/E that offers no margin of safety. The structural vulnerability is acute: contracted radiology groups operate all medical services, and terminatio
RDNT's current Stocky Verdict is 17/100, placing it in the "Avoid" band. This composite combines a 18/100 Compounder score, 42/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for RDNT yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
RDNT scores 42/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
RDNT's Vulnerability Profile scores 17/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to RDNT.
Sign up free and unlock the full analysis on RDNT — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
Or jump straight to the interactive dashboard for RDNT in the app.
